Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 8

1.

Clinical implications of Brief Psychiatric Rating Scale scores.

Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R.

Br J Psychiatry. 2005 Oct;187:366-71.

2.

Practical issues with amisulpride in the management of patients with schizophrenia.

Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.

Clin Drug Investig. 2008;28(8):465-77. Review.

PMID:
18598092
3.

Clinical relevance of findings in trials of antipsychotics: systematic review.

Lepping P, Sambhi RS, Whittington R, Lane S, Poole R.

Br J Psychiatry. 2011 May;198(5):341-5. doi: 10.1192/bjp.bp.109.075366. Review.

4.

Symptom rating scales and outcome in schizophrenia.

Mortimer AM.

Br J Psychiatry Suppl. 2007 Aug;50:s7-14. Review.

PMID:
18019038
5.

Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation.

Suzuki T, Remington G, Mulsant BH, Uchida H, Rajji TK, Graff-Guerrero A, Mimura M, Mamo DC.

Psychiatry Res. 2012 May 15;197(1-2):1-6. doi: 10.1016/j.psychres.2012.02.013. Epub 2012 Mar 18. Review.

PMID:
22429484
6.

Chinese herbal medicine for schizophrenia: cochrane systematic review of randomised trials.

Rathbone J, Zhang L, Zhang M, Xia J, Liu X, Yang Y, Adams CE.

Br J Psychiatry. 2007 May;190:379-84. Review.

7.

Relationships between global assessment of functioning and other rating scales in clinical trials for schizophrenia.

Suzuki T, Uchida H, Sakurai H, Ishizuki T, Tsunoda K, Takeuchi H, Mimura M.

Psychiatry Res. 2015 Jun 30;227(2-3):265-9. doi: 10.1016/j.psychres.2015.02.024. Epub 2015 Apr 1. Review.

PMID:
25882098
8.

Tools to assess negative symptoms in schizophrenia.

Kane JM.

J Clin Psychiatry. 2013 Jun;74(6):e12. doi: 10.4088/JCP.12045tx2c. Review.

PMID:
23842020
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk